HKU Scholars Hub: Search

Search

Results 1-25 of 200 (Search time: 0.026 seconds).

previous
1
2
3
4
...
8
next

	Title	Author(s)	Issue Date	Views
	Sequential continual reassessment method for two-dimensional dose finding. Journal:Statistics in medicine	Yuan, Y Yin, G	2008	119
	Sieve maximum likelihood estimation for a general class of accelerated hazards models with bundled parameters Journal:Bernoulli	Zhao, X Wu, Y Yin, G	2017	38
	Subgroup Analysis in Censored Linear Regression Journal:Statistica Sinica	Yan, X Yin, G Zhao, X	2020	31
	Multiple change-points detection in high dimension Journal:Random Matrices: Theory and Applications	Wang, Y Zou, C Wang, Z Yin, G	2019	36
	Demystify Lindley’s paradox by connecting p-value and posterior probability Journal:Statistics and its Interface	Yin, G Shi, H	2021	6
	Convergence rates of the blocked Gibbs sampler with random scan in the Wasserstein metric Journal:Stochastics	Wang, NY Yin, G	2020	43
	Reduction in number to treat versus number needed to treat Journal:BMC Medical Research Methodology	ZHANG, C Yin, G	2021	12
	Comparison of Transmissibility of Coronavirus Between Symptomatic and Asymptomatic Patients: Reanalysis of the Ningbo COVID-19 Data Journal:JMIR Public Health and Surveillance	Yin, G JIN, H	2020	45
	Ensemble approaches to estimating the population mean with missing response Journal:Scandinavian Journal of Statistics: theory and applications	Duan, X Yin, G	2017	47
	Bayesian frailty models based on box-cox transformed hazards Journal:Statistica Sinica	Yin, G Ibrahim, JG	2005	96
	Censored cumulative residual independent screening for ultrahigh-dimensional survival data Journal:Lifetime Data Analysis	Zhang, J Yin, G Liu, Y Wu, Y	2018	72
	Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma Journal:Cancer	Rivera, E Meyers, C Groves, M Valero, V Francis, D Arun, B Broglio, K Yin, G Hortobagyi, GN Buchholz, T	2006	118
	Comments on ‘Competing designs for drug combination in phase I dose-finding clinical trials’ by M-K. Riviere, F. Dubois, and S. Zohar Journal:Statistics in Medicine	Yin, G LIN, R	2015	51
	Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies Journal:Circulation	McCaw, ZR Yin, G Wei, LJ	2019	16
	Bayesian dose finding in oncology for drug combinations by copula regression: Authors' response Journal:Journal of the Royal Statistical Society. Series C: Applied Statistics	Yin, G Yuan, Y	2010	90
	Crystallization Learning with the Delaunay Triangulation Proceeding/Conference:Proceedings of Machine Learning Research (PMLR)	Gu, J Yin, G	2021	13
	Bayesian generalized method of moments Proceeding/Conference:Joint Statistical Meetings, Vancouver, JSM 2010	Yin, G	2010	39
	Bayesian Model Selection Approach to Multiple Change-Points Detection with Non-Local Prior Distributions Journal:ACM Transactions on Knowledge Discovery from Data	Jiang, F Yin, G Dominici, F	2019	46
	Clinical Trial Design: Bayesian and Frequentist Adaptive Methods	Yin, G	2012	154
	Robust EM continual reassessment method in oncology dose finding Journal:Journal of the American Statistical Association	Yuan, Y Yin, G	2011	110
	Boosting conditional logit model Journal:Journal of Choice Modelling	SHI, H Yin, G	2018	93
	Bayesian randomized clinical trials: from fixed to adaptive design Journal:Contemporary Clinical Trials	Yin, G LAM, CK SHI, H	2017	58
	Response‐adaptive rerandomization Journal:Journal of the Royal Statistical Society: Series C (Applied Statistics)	ZHANG, H Yin, G	2021	5
	Bayesian enhancement two‐stage design with error control for phase II clinical trials Journal:Statistics in Medicine	JIN, H Yin, G	2020	29
	Divide-and-Conquer for Accelerated Failure Time Model with Massive Time-to-Event Data	SU, W Yin, G Zhang, J Zhao, X	2022	4